Valuation : Adocia

Market Cap 78.62M 91.13M 73.97M 67.43M 127M 8.65B 128M 876M 340M 4.4B 342M 335M 14.6B P/E 2026 *
-733x
P/E 2027 * 5.81x
Enterprise Value 48.77M 56.54M 45.89M 41.83M 78.56M 5.37B 79.12M 544M 211M 2.73B 212M 208M 9.06B EV / Sales 2026 *
19.3x
EV / Sales 2027 * 3.07x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.75%
1 week-1.03%
Current month+0.75%
1 month+1.46%
3 months-18.57%
6 months-40.03%
Current year-40.03%
1 week 3.92
Extreme 3.92
4.09
1 month 3.87
Extreme 3.866
4.3
Current year 3.61
Extreme 3.61
7.45
1 year 3.61
Extreme 3.61
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 2023-05-10
Director of Finance/CFO - 2024-09-22
Chief Tech/Sci/R&D Officer - 2014-11-30
Director TitleAgeSince
Director/Board Member 55 2013-04-18
Chairman 80 2012-02-23
Director/Board Member 58 2013-06-17
Date Insider Type Main position Quantity % Market Cap. Importance
2/27/25 Buy

Founder

109,170 0.6972%
4/6/24 Buy

Founder

15,576 0.1105%
4/6/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+0.75%-1.03%-51.47%-64.51% 90.63M
-0.25%-0.92%+49.47%+89.45% 68.13B
+1.21%+2.55%+46.72%+90.66% 63.6B
+1.31%+1.81%+49.04%+12.07% 25.57B
-0.25%-1.99%-10.72%+455.09% 26.6B
+0.33%-9.64%+1.95%-15.70% 25.52B
-6.09%-11.19%+224.80%+351.08% 18.23B
+1.18%+1.66%+35.20%-18.67% 19.69B
-1.49%-6.35%+7.84%+540.26% 15.16B
+4.12%+4.29%+52.03%+154.09% 13.54B
Average +0.08%-3.63%+40.48%+159.38% 27.61B
Weighted average by Cap. +0.15%-2.86%+46.97%+145.51%

Financials

2026 *2027 *
Net sales 2.52M 2.92M 2.37M 2.16M 4.06M 278M 4.09M 28.11M 10.92M 141M 10.97M 10.73M 468M 35.4M 41.04M 33.31M 30.36M 57.02M 3.9B 57.42M 395M 153M 1.98B 154M 151M 6.57B
Net income -4.32M -5M -4.06M -3.7M -6.95M -475M -7M -48.13M -18.69M -242M -18.79M -18.38M -802M -44.33M -51.39M -41.71M -38.02M -71.4M -4.88B -71.91M -494M -192M -2.48B -193M -189M -8.23B
Net Debt -29.84M -34.6M -28.08M -25.6M -48.07M -3.29B -48.41M -333M -129M -1.67B -130M -127M -5.54B 30.18M 34.98M 28.39M 25.88M 48.61M 3.32B 48.95M 336M 131M 1.69B 131M 128M 5.6B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
26-09-01 €4.018 +0.75% 55,333
26-08-31 €3.988 -0.20% 46,017
26-08-28 €3.996 -0.40% 31,732
26-08-27 €4.012 +0.80% 37,398
26-08-26 €3.980 -0.75% 90,232
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
4.018EUR
Average target price
9.700EUR
Spread / Average Target
+141.41%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock